Shanghai Songli biology led the formulation of ASTM International Standards for the first time
Yiou, August 31 - on August 1, the ASTM (American Society for testing materials) international standard ASTM F 3515-21 Standard Guide, characteristics and testing of porcine fibrinogen as a starting material for biomedical and tissue engineering medical products, which was first developed by Shanghai Songli Biotechnology Co., Ltd., was officially released by ASTM International, The standard will help to provide more raw material choices for the field of regenerative medicine.
This text is a result of machine translation.
Briefing Jan 13, 2022 10:31 PM
· Healthcare
Zhizhun · Zhi · Jian, the world's smallest micro neurosurgical robot system, was approved for listing
Briefing Jan 06, 2022 03:39 PM
· Healthcare
Xinmai medical announced strategic cooperation with rainbow medical, a famous medical device incubator in Israel
In depth
Briefing Jan 06, 2022 11:27 AM
· Healthcare
Hengrui medicine has been introduced for more than US $100 million! New antifungal drugs applied for listing in China
Briefing Dec 31, 2021 06:27 PM
· Healthcare
The IPO of Lianying medical technology innovation board has been accepted by Shanghai Stock Exchange
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Aug 09, 2020 12:23 AM
Research
Real Estate, Industrials, FinancialsTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Briefing Dec 31, 2021 02:06 PM
· Healthcare
The first KRAS concomitant diagnostic PCR kit in China was approved for marketing
Briefing Dec 31, 2021 02:00 PM
· Healthcare
China's new crown oral drug vv116 has been authorized for emergency use in Uzbekistan
Briefing Dec 31, 2021 01:57 PM
· Healthcare
Wu Kun, chief operating officer of Pfizer China, will leave
Briefing Dec 31, 2021 01:55 PM
· Healthcare
Samsung Bio said the acquisition of Bojian was untrue
In depth
Briefing Dec 30, 2021 08:58 AM
· Healthcare
Jdb175 and jdb153 tablets, a class I new drug of Jiabao Yaoyin, have been approved for clinical trial by China food and drug administration
Briefing Dec 29, 2021 08:03 AM
· Healthcare
Consumer medical SaaS + trading platform Lingjian completed D + round of financing
Briefing Dec 29, 2021 08:03 AM
· Healthcare
Consumer medical SaaS + trading platform Lingjian completed D + round of financing
Healthcare
Dada group's revenue rose nearly 30% in the third quarter, and JD's "hour purchase" cont
Looking forward to the fourth quarter of 2021, dada Group expects its total revenue to be between 2 billion yuan and 2.1 billion yuan. On the premise that the last kilometer of dada express delivery service is consistent with the comparable basis, the total revenue in the fourth quarter of 2021 will achieve a year-on-year increase of 88% to 97%.
Nov 24, 2021 11:42 AM
Briefing Dec 28, 2021 11:33 AM
· Healthcare
Aosikang biology completed a new round of financing of RMB 1.5 billion
Briefing Dec 28, 2021 11:17 AM
· Healthcare
Focusing on neurodegeneration, aprinoia therapeutics completed round C financing of US $40 million
Briefing Dec 28, 2021 10:50 AM
· Healthcare
Yuanjingtaike obtained tens of millions of yuan of PREA round financing and was invested exclusively by Yuansheng venture capital
Briefing Dec 27, 2021 08:56 PM
· Healthcare
Phase III clinical trial of prochloramide, a new crown drug in the pharmaceutical industry, failed in the United States
See more
Read next
Insight
Technology
Another Look at China's Semiconductor Manufacturing Equipment Industry
Jan 19, 2022 02:58 PM
Insight
In depth
Automotive
Carnex: A Growing Life Cycle Used EV Platform Founded by Tesla Enthusiasts
Jan 19, 2022 07:59 AM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.